-
Wellness for Everybody—in Every Body
In recent years, several qualitative studies have given us field notes of patients describing their experiences having larger bodies and interacting... -
Glucagon-Like Peptide-1 Receptor Agonists: A Pharmacy Perspective on Insurance Coverage and Medication Access
Glucagon-like peptide-1 receptor agonists, more commonly referred to as GLP-1s, have undoubtedly garnered much fanfare the past five years. This... -
My Journey with GLP-1 Weight Loss Drugs: Managing PCOS, Celiac Disease, and Metabolic Health
In my thirties, my body began to “betray” me. After years of running marathons, working out, and eating well, I found myself struggling with...
Archive
Perspectives in Primary Care features writing from practitioners, activists, and community members representing organizations, practices, and institutions across the United States and around the world.
Reference
Update in Weight Management within Primary Care in the Era of GLP-1
Note: this piece is an update to the 2024 article Integrating Weight Management in Primary Care, published in this journal, which outlined practical methods to initiating and monitoring patient-centered weight management in a primary care setting. This article specifically addresses the use of GLP-1 and GIP receptor agonists. The availability and increasing popularity of glucagon-like peptide-1 (GLP-1) ...
Reference
Integrating Weight Management in Primary Care
The obesity prevalence among U.S. adults has increased at an alarming rate in the past several decades, reaching 42 percent in 2018 or about 110 million people based on census data. By 2035, the prevalence of obesity in the U.S. is expected to reach 58 percent, with the total ...
